| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.33 | 0.3 |